8-K
filed May 29, 2026, 4:35 PM ET
ticker KNSA
CIK 0001730430
other
confidence high
sentiment neutral
materiality 0.15
Kiniksa shareholders re-elect all three Class II directors and approve all eight proposals at 2026 annual meeting
Kiniksa Pharmaceuticals International, plc
- Stephen R. Biggar re-elected with 37.5M for, 12.0M against; G. Bradley Cole and Barry D. Quart each received ~48.3M for.
- PricewaterhouseCoopers LLP approved as both UK statutory auditor and US independent auditor with overwhelming votes.
- Advisory vote on named executive officer compensation passed with 48.1M for and 1.3M against.
- All eight proposals, including director elections, auditor appointments, and remuneration reports, were duly passed.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001730430-26-000029
- form_type
- 8-K
- ticker
- KNSA
- cik
- 0001730430
- company_name
- Kiniksa Pharmaceuticals International, plc
- filed_at
- 2026-05-29T20:35:27+00:00
- discovered_at
- 2026-05-29T20:36:00.520063+00:00
- generated_at
- 2026-05-29T20:36:59.359555+00:00
- sec_items
- ["5.07"]
- event_type
- other
- sentiment
- neutral
- materiality_score
- 0.25
- calibrated_materiality_score
- 0.15
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001730430-26-000029
- json_url
- https://secwatch.observer/filing/0001730430-26-000029.json
- markdown_url
- https://secwatch.observer/filing/0001730430-26-000029.md
- text_url
- https://secwatch.observer/filing/0001730430-26-000029.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1730430/000173043026000029/0001730430-26-000029-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1730430/000173043026000029/knsa-20260529x8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
MERC
Mercer International shareholders elect all director nominees, approve say-on-pay, ratify PwC
MERCER INTERNATIONAL INC.
June 1, 2026, 5:26 PM ET
other
Items 5.07
same SEC item: 5.07
same event type: other
similar materiality
Filing page
SEC filing
BMRC
Bank of Marin shareholders elect all 10 directors, approve say-on-pay, ratify auditor
Bank of Marin Bancorp
June 1, 2026, 5:11 PM ET
other
Items 5.07, 8.01
same SEC item: 5.07
same event type: other
similar materiality
Filing page
SEC filing
XBP
XBP Global Holdings annual meeting elects directors, approves auditor and say-on-pay
XBP Global Holdings, Inc.
June 1, 2026, 5:00 PM ET
other
Items 5.07, 9.01
same SEC item: 5.07
same event type: other
similar materiality
Filing page
SEC filing
NWN
NWN shareholders elect three directors, approve say-on-pay, ratify PwC
Northwest Natural Holding Co
June 1, 2026, 4:21 PM ET
other
Items 5.07
same SEC item: 5.07
same event type: other
similar materiality
Filing page
SEC filing
GTX
Garrett Motion shareholders elect all eight directors and ratify Deloitte as auditor
Garrett Motion Inc.
June 1, 2026, 4:16 PM ET
other
Items 5.07
same SEC item: 5.07
same event type: other
similar materiality
Filing page
SEC filing
CLAR
Clarus shareholders elect all five director nominees, approve say-on-pay and auditor ratification
Clarus Corp
June 1, 2026, 4:15 PM ET
other
Items 5.07
same SEC item: 5.07
same event type: other
similar materiality
Filing page
SEC filing
AAT
AAT stockholders elect all five director nominees, ratify EY as auditor at 2026 annual meeting
American Assets Trust, Inc.
June 1, 2026, 4:15 PM ET
other
Items 5.07
same SEC item: 5.07
same event type: other
similar materiality
Filing page
SEC filing
AXON
Axon shareholders elect all 9 director nominees and approve say-on-pay at 2026 annual meeting
AXON ENTERPRISE, INC.
June 1, 2026, 4:10 PM ET
other
Items 5.07, 9.01
same SEC item: 5.07
same event type: other
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.